Vericel to Present at Multiple Upcoming Investor Conferences
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the following investor conferences:
- TD Cowen 46
thAnnual Healthcare Conference on Wednesday, March 4th, 2026
- Leerink Partners 2026 Global Healthcare Conference on Tuesday, March 10
th, 2026
A webcast of the presentations will be available on the Investor Relations section of the Vericel Corporation website.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI
Epicel
Investor Contact:
Eric Burns
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sui trades at $1.15 after rebound, analysts target $1.27 resistance
Miata drills 3.4 g gold at Sela Creek in Suriname
NASDAQ TRADE HALT <RZAI.O> VOLATILITY TRADING PAUSE AT 09:36 AM
Aave’s Securities and GPU Expansion Puts AAVE Token Burn in Focus

